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neurogenesis. Concerning quiescence, more Sox2+NSCs 
express FoxO3 after 30GyFLASH-RT than in CONV-RT groups. 
Nevertheless, the number of Sox2+FoxO3+NSCs decreases at 
higher doses probably due to the RT-induced cell death. 
Altogether these results suggest that FLASH-WBRT induces 
different responses in the NSCs compared to CONV-RT. 
Indeed, FLASH-RT does not induce cognitive impairment two 
months post-IR compared to CONV-RT. This observation 
correlates with a preservation of neurogenesis in the SGZ. 
Moreover, after FLASH-RT, SVZ NSCs show a quiescent status 
which could explain their preservation after irradiation and 
their ability to re-induce neurogenesis. 
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Purpose: The purpose of the reported research is the 
elaboration of the method for construction of the cost-
effective whole-body single-bed positron emission 
tomography scanner enabling simultaneous PET/CT and 
PET/MRI imaging.   
Material and methods: The Jagiellonian Positron Emission 
Tomography scanner (J-PET) is built out of axially arranged 
plastic scintillator strips, forming a cylinder [1]. The light 
signals produced in scintillators are converted to electrical 
pulses by photomultipliers placed at opposite ends of each 
strip [2]. The pulses are probed in the voltage domain by a 
newly developed electronics [1,3], and are collected by the 
novel trigger-less and reconfigurable data acquisition system 
[1,4]. The hit-position and hit-time of gamma quanta are 
reconstructed based on the time of arrival of light signals to 
the ends of the scintillator strips. The reconstruction 
procedures make use of the compressing sensing theory [5,6] 
and the library of synchronized model signals [1,7]. 
Moreover, for the image reconstruction novel algorithms are 
being developed and adopted for fast iterations on the 
graphics processing units [8].  
For estimation of the J-PET characteristics the computer 
simulations were performed [9] using GATE package [10]. 
Simulations were conducted taking into account known 
physical and instrumental effects as e.g. photon emission 
spectrum, time distribution of emitted photons, losses and 
time spread of photons due to their propagation through the 
scintillator, as well as quantum efficiency and transit time 
spread of photomultipliers. 
Results: In autumn 2015 a construction of the full scale J-PET 
prototype was completed. J-PET consists of 192 strips 
arranged axially in three layers forming a cylindrical 
diagnostic chamber with the diameter of 85 cm and axial 
field-of-view (AFOV) of 50 cm, and it is characterized by 300 
ps coincidence resolving time.  
The performance characteristics, simulated according to 
standards defined by the National Electrical Manufacturers 
Association (NEMA-NU-2), indicate a comparable performance 
of the J-PET with respect to current TOF-PET modalities as 
regards e.g. accidental coincidences [9], sensitivity, scatter 
fraction and point spread function.  
Conclusions: An axial arrangement of long strips of plastic 
scintillators, and their small light attenuation allows us to 
make a TOF-PET scanner with a longAFOV. 
The estimated coincidence resolving time changes from 230 
ps to 430 ps when extending AFOV from 16 cm to 100 cm. 
This result opens perspectives for construction of the cost 
effective TOF-PET scanner with significantly improved TOF 
resolution and larger AFOV with respect to the current 
TOF-PET modalities [11,12]. 
The talk will include presentation of the J-PET scanner along 
with the description of its characteristics estimated 
according to NEMA-NU-2 standards, and presentation of 
perspectives of combining J-PET with CT and MRI. 
 
Keywords: Time-of-Flight Positron Emission Tomography, 
Plastic Scintillators, PET/MRI 
 
References: 
[1] Patents granted: EP2454612B1, WO2011008119, 
EP2454611B1, WO2011008118 and further 14 International 
Patent Applications available at 
http://koza.if.uj.edu.pl/patents/ and at 
http://worldwide.espacenet.com/  
[2] P. Moskal et al., Nucl. Inst. and Meth. A 764 (2014) 317. 
[3] M. Pałka et al., Bio Algorithms and Med-Systems 10 (2014) 
41. 
[4] G. Korcyl et al., Bio-Algorithms and Med-Systems 10 
(2014) 37. 
[5] L. Raczynski et al., Nucl. Inst. and Meth. A 764 (2014) 
186. 
[6] L. Raczynski et al., Nucl. Instr. Meth. A 786 (2015) 105. 
[7] P. Moskal et al., Nucl. Inst. and Meth. A 775 (2015) 54. 
[8] P. Białas et al., Acta Phys. Polon. A 127 (2015) 1500. 
[9] P. Kowalski et al., Acta Phys. Polon. A 127 (2015) 1505. 
[10] S. Jan et al., Phys. Med. Biol. 49, 4543 (2004). 
[11] Conti M, Eur. J. Nucl. Med. Mol. Imaging 38 (2011) 1147. 
[12] Bettinardi V et al., Medical Physics 38 (2011) 5394. 
 
157 
Targeted Radionuclide Therapy with 161Tb: Investigation of 
Anti-Tumor Effects and Undesired Side Effects 
C. Müller1, S. Haller1, C. Vermeulen1, U. Köster2, G. 
Pellegrini3, R. Schibli1,4, N.P. van der Meulen1,5 
1 Center for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul 
Scherrer Institute, Villigen-PSI, Switzerland 
2 Institut Laue-Langevin, Grenoble, France 
3 Laboratory for Animal Model Pathology (LAMP), Institute of 
Veterinary Pathology, Vetsuisse Faculty, University of Zurich, 
Zurich, Switzerland 
4 Department of Chemistry and Applied Biosciences, ETH 
Zurich, Zurich, Switzerland 
5 Laboratory of Radiochemistry and Environmental Chemistry, 
Paul Scherrer Institute, Villigen-PSI, Switzerland 
 
Purpose: The radiolanthanide 161Tb (T1/2 = 6.89 d) emits β--
particles (Eβ- = 154 keV) similar to 177Lu (T1/2 = 6.64 d, Eβ- = 34 
KeV), but also a significant number of Auger electrons (~12e-
/decay). This radiation profile may result in more efficient 
tumor cell killing, in particular, if the radioconjugate targets 
the cellular nucleus where DNA is damaged by the short-
ranged Auger electrons. Herein, we investigated 161Tb in 
combination with folate and somatostatin analogs in vitro 
and in vivo and compared the results to those obtained with 
the 177Lu-labeled pendants. 
Materials/methods: 161Tb was produced via irradiation of a Gd 
target at the reactor at ILL and separated from the target 
material by ion exchange chromatography at PSI. A DOTA-
folate conjugate (cm10, [1]) was labeled with 161Tb and 177Lu 
and investigated in mice. The KB tumor sizes were measured 
and undesired side effects were monitored by determination 
of body weights and blood plasma parameters (BUN, 
creatinine), as well as histological investigation, as previously 
reported [2]. DOTATOC and its analog DOTATOC-NLS, which 
contains a nuclear localizing signal (NLS), were labeled with 
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161Tb (30 MBq/nmol) and investigated in vitro using 
somatostatin receptor-positive AR42J rat tumor cells. 
Viability and survival assays were performed in vitro. 
Results: In vivo application of 161Tb-folate (10 MBq) resulted 
in a reduced KB tumor growth and, as a consequence, in an 
increased survival time (54 d) of mice compared to those 
treated with 177Lu-folate (10 MBq, 35 d) [3]. Based on BUN 
and creatinine plasma values and histological investigations 
of renal tissues, 161Tb-folate did not result in more severe 
damage to the kidneys than 177Lu-folate, however. In vitro 
investigations with 161Tb-DOTATOC and 161Tb-DOTATOC-NLS 
revealed comparable uptake into AR42J cells, but 
externalization of 161Tb-DOTATOC-NLS was lower (~25%) than 
for 161Tb-DOTATOC (~55%) after 6 h. After 2 h of incubation 
the fraction of internalized 161Tb-DOTATOC-NLS, which was 
localized in the nucleus (~3%), was significantly higher than 
the fraction of 161Tb-DOTATOC (<0.5%). AR42J cell killing 
after application of 161Tb-DOTATOC-NLS was more effective 
(IC50 ~1.5 MBq/mL) than after treatment with 161Tb-
DOTATOC (IC50 ~8 MBq/mL). 
Conclusion: Due to additional Auger electron emission, 161Tb 
appears to be more effective for tumor treatment than 177Lu. 
The effect caused by Auger electrons was found to be more 
powerful if the radioconjugate targets the cellular nucleus by 
means of a NLS. Interestingly, kidney damage was not 
enhanced after therapy with 161Tb compared to the 
treatment with 177Lu. Based on these findings, 161Tb has a 
great potential to be used in future clinical practice as it may 
kill single cancer cells and cell clusters more efficiently than 
177Lu without causing additional side effects. 
 
Keywords: 161Tb, Auger electron, nuclear localizing signal 
 
References: 
[1] Müller et al. 2013 J Nucl Med 1:124-131. 
[2] Haller et al. 2015 Nucl Med Biol 42:770-779 
[3] Müller et al. 2014 Eur J Nucl Med Mol Imaging 41:476-485. 
 
158 
The GEMPIX detector for energy deposition measurements 
in Hadrontherapy 
F. Murtas1,2, M. Ciocca3, S.P.George1, A.Mirandola3, 
A. Rimoldi4, M. Silari1, A. Tamborini4 
1 CERN  
2 LNF-INFN  
3 Centro Nazionale di Adroterapia Oncologica  
4 University of Pavia & INFN 
 
A triple GEM detector with a 55 μm pitch pixelated ASIC for 
the readout has been used at CNAO in Pavia for a detailed 
measurements of energy deposition inside a water phantom. 
The detector was operated with a gas mixture of Ar CO2 CF4 
at a moderate gain and the measurements were performed 
with a beam of 120 MeV protons and 330 MeV/u Carbon ions. 
The energy deposition was measured at different positions in 
depth allowing a 3D reconstruction of the beam inside the 
phantom as shown in the figure. A small number of single 
event upsets in the pixel readout appear only in the Bragg 
peak and the DAQ can recover them for each acquisition. A 
detailed simulation was performed with GEANT4 and it was 
found in good agreement with the experimental data. 
The future uses and upgrade of this device, including its 
potential application in microdosimetry, are discussed. 
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The need for an open-access biomedical research facility was 
first raised by the scientific community at the 2010 Physics 
for Health workshop, where CERN was asked to take the lead 
on this initiative.  
In 2012, a brainstorming meeting evaluated the possibility of 
modifying the existing CERN Low Energy Ion Ring (LEIR) 
accelerator to establish such an infrastructure.  The medical 
and radiobiological communities united in broad agreement 
on the need for such a dedicated research facility. 
The Biomedical facility at CERN (OPEN-MED) would create an 
open collaborative biomedical research infrastructure. By 
sharing the facility internationally, more rapid progress can 
be made by: 
• Complementary collaboration with leading 
universities, research facilities and industry  
• Comprehensively investigate complex physical and 
biological parameters that control radiation cell 
killing efficiency under highly controlled 
conditions.  
• Provide accurate data for the modelling of 
radiation effects for proton and ion beam clinical 
applications 
• Study comparative beam ballistics and dosimetry in 
phantoms and so improve predicted physical dose 
distributions.    
• Provide a range of beams and infrastructure for 
developing new instrumentation for detection and 
imaging. 
• Provide adequate beam time  
